Technical Analysis for IPA - ImmunoPrecise Antibodies Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Fell Below 20 DMA | Bearish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Outside Day | Range Expansion | 0.00% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -2.29% | |
Crossed Above 20 DMA | Bullish | -2.29% |
Alert | Time |
---|---|
Possible NR7 | about 9 hours ago |
Possible Inside Day | about 9 hours ago |
10 DMA Support | about 10 hours ago |
20 DMA Support | about 12 hours ago |
60 Minute Opening Range Breakdown | about 12 hours ago |
Get a Trading Sidekick!
- Earnings date: 03/14/2024
ImmunoPrecise Antibodies Ltd. Description
ImmunoPrecise Antibodies Ltd. engages in the antibody production and related services in the United States, Canada, Europe, and internationally. Its services include B cell sorting, screening and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multispecies antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing, purification in gram scale levels, and characterization and validation; antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with screening and clone-picking; cryopreservation; affinity measurements, functional assays, and epitope mapping and binning; and modeling, design, and manufacturing of custom antigen. The company has a collaboration with University of Victoria to develop a saliva-based antibody-based test for the detection and screening of COVID-19; Zymeworks Inc. for the development of multiple antibody candidates to fight COVID-19; and National Research Council of Canada's Human Health Therapeutics Research Centre to develop neutralizing PolyTope antibodies against SARS-CoV-2, as well as a research partnership with Mila. ImmunoPrecise Antibodies Ltd. was founded in 1989 and is headquartered in Fargo, North Dakota.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Immunology Antibodies Monoclonal Antibody Antibody Cloning Screening
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.22 |
52 Week Low | 0.95 |
Average Volume | 718,192 |
200-Day Moving Average | 1.68 |
50-Day Moving Average | 1.45 |
20-Day Moving Average | 1.28 |
10-Day Moving Average | 1.28 |
Average True Range | 0.09 |
RSI (14) | 44.13 |
ADX | 15.63 |
+DI | 16.36 |
-DI | 20.07 |
Chandelier Exit (Long, 3 ATRs) | 1.18 |
Chandelier Exit (Short, 3 ATRs) | 1.44 |
Upper Bollinger Bands | 1.37 |
Lower Bollinger Band | 1.18 |
Percent B (%b) | 0.51 |
BandWidth | 14.94 |
MACD Line | -0.05 |
MACD Signal Line | -0.06 |
MACD Histogram | 0.0155 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.34 | ||||
Resistance 3 (R3) | 1.34 | 1.32 | 1.33 | ||
Resistance 2 (R2) | 1.32 | 1.30 | 1.32 | 1.33 | |
Resistance 1 (R1) | 1.30 | 1.30 | 1.29 | 1.30 | 1.32 |
Pivot Point | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 |
Support 1 (S1) | 1.26 | 1.26 | 1.25 | 1.26 | 1.24 |
Support 2 (S2) | 1.24 | 1.26 | 1.24 | 1.23 | |
Support 3 (S3) | 1.22 | 1.24 | 1.23 | ||
Support 4 (S4) | 1.22 |